Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

New head at Bayer’s Animal Health division

April 27, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer Healthcare, Dirk Ehle, animal health

Dr Dirk Ehle has been appointed Head of the Animal Health Division of Bayer.  The 42-year-old succeeds Dr Jean-Luc Lowinski, …
Appointment

Watson buys Actavis to create generics giant

April 27, 2012 Sales and Marketing Actavis, Watson, generics

Watson Pharmaceuticals is to buy rival Actavis Group in a move that will create the third largest generics manufacturer in …
News

Brennan bows to pressure and quits AstraZeneca

April 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, David Brennan, Q1, pharma

AstraZeneca’s chief executive David Brennan is to step down from his post following mounting dissatisfaction with his leadership. Brennan, who …
News

Novartis Q1 earnings slide down

April 26, 2012 Sales and Marketing Novartis, Q1, Sandoz, generics, gilenya

Generic competition and problems at a US plant were among the reasons why Novartis’ sales and profit dipped in the …
News

Two new hep C pills recommended by NICE

April 25, 2012 Sales and Marketing Incivo, Janssen, MSD, NICE, Victrelis, hep C

NICE has given its final recommendation for two new hepatitis C pills in an expedited review.  Janssen’s Incivo (telaprevir) and …
News

A family business: Pradaxa success lifts Boehringer

April 25, 2012 Research and Development, Sales and Marketing Boehringer Ingelheim

Rapid uptake of anti-clotting drug Pradaxa in the US has helped Boehringer Ingelheim enjoy a strong year, and looks set to …
Feature

GMC won’t relax off-label prescribing guidelines

April 25, 2012 Sales and Marketing GMC, Lucentis, Novartis, Roche, avastin, off label, off-label

The GMC has decided not to relax guidelines on off-label prescribing when a licensed alternative exists. The GMC’s current rules …
News

Paul Mannu joins Insight Research Group as consultant

April 25, 2012 Business Services, Medical Communications, Sales and Marketing Cello, Insight Research Group

Paul Mannu has joined the senior research team at Insight Research Group as a consultant. For the last few years Paul …
Appointment

Merck KGaA swings axe over Serono operations

April 25, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Cladribine, MS, Merck KGaA, Switzerland, job cuts

Merck KGaA will cut around 500 jobs from its pharmaceutical unit in Switzerland, the firm has announced.  The company said …
News

New data shows Herceptin’s ability to increase survival

April 24, 2012 Research and Development, Sales and Marketing Cancer, Cochrane, Herceptin, Roche, breast

A new review of Roche’s breast cancer drug Herceptin has confirmed its ability to increase overall survival, but concerns remain …
News

Shire’s Vpriv website in breach of ABPI Code

April 24, 2012 Medical Communications, Sales and Marketing ABPI, Genzyme, PMCPA, Shire, Vpriv, code

Shire’s website for its Gaucher’s disease drug Vpriv has fallen foul of the ABPI’s Code of Conduct.  The complaint was …
News

7 steps to better talent acquisition

April 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, Talent acquisition, careers, executives

When companies complain that they can’t find enough good people, the cause, in our view, is most likely to be …
Feature

Charity challenges government on Avastin for wet AMD

April 24, 2012 Sales and Marketing Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD

A leading patient group has called on the government to get to grips with the issue of off-label prescribing, as …
News

Quintiles appoints Tom Pike as new chief executive

April 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Quintiles, Tom Pike, biopharmaceutical

Quintiles, the biopharmaceutical services company, has appointed Tom Pike as its new chief executive, effective from 30 April. The appointment …
Appointment

Government to speed up access to new cancer drugs

April 24, 2012 Sales and Marketing CDF, Cancer, Roche, UK, avastin, government, sha

Access to England’s Cancer Drugs Fund will be speeded up, ministers have confirmed.  Currently, it can take a number of …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026